The European Thoracic Oncology Platform (ETOP) found that in a well-defined NSCLC Lungscape cohort of 1572 patients, both MET amplification and MET gene copy number (GCN) were significantly associated with IHC MET positivity (p < 0.001) [5]. This evidence concerns the gene MET and non-small cell lung carcinoma.